Over the last few decades, the world has seen a range of commercially successful products. This is especially true in the pharma sector, as blockbuster drugs yield exceedingly high revenues. The main reason for the commercial success of these drugs is the fact that the underlying active ingredients are protected by patents. Hence, the drug can be sold exclusively. After these patents reach their 20-year maximum lifetime, cheaper generics usually enter the market, drastically decreasing revenue for the original drug. To tackle the effects of such patent cliffs, companies try to extend the patent protection of their blockbuster technology. In this webinar, we will have a look at the most common strategies and how to spot them.

• How to identify relevant patent cliffs
• How to map patents to products
• Common ways to extend the patent protection of a technology
• How to identify these extension strategies

Join Gene Quinn, patent attorney and founder of IPWatchdog.com, for a conversation about drug patents in the pharma sector. Joining Gene will be Kae Gruner, Associate General Counsel at Acella Pharmaceuticals, and Sarbini Chattopadhyay, Consultant with PatentSight.

This Webinar is Sponsored By: